COMMUNIQUÉS West-GlobeNewswire
-
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
15/04/2026 -
Alira Health and Autoimmune Neurology Alliance (AiNA) Launch AXIS Registry, Advancing Real-World and Patient-Centered Research in Autoimmune Neurology
15/04/2026 -
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
15/04/2026 -
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
15/04/2026 -
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
15/04/2026 -
Cerene® by Channel Medsystems Partners with Hey Girl! Fund to Support Menstrual Education at Caregivers & Girlies Brunch on Saturday, April 18
15/04/2026 -
Walking Yoga App: How Combining Walking and Yoga Accelerates Weight Loss
15/04/2026 -
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform
15/04/2026 -
NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments
15/04/2026 -
The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future
15/04/2026 -
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
15/04/2026 -
Annual General Meeting of Kuros Biosciences approves all resolutions
15/04/2026 -
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15/04/2026 -
BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
15/04/2026 -
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
15/04/2026 -
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
15/04/2026 -
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
15/04/2026 -
Scienture Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
15/04/2026 -
Sienna Announces April Dividend
15/04/2026
Pages